Meeting
2019 ASCO Annual Meeting
Patient controlled analgesia (PCA) versus non-PCA intravenous hydromorphone titration for severe cancer pain: A randomized, controlled, multicenter, phase III trial, HMORCT09-1.
Authors
Rongbo Lin
Gastrointestinal Medical Oncology, Fujian Cancer Hospital., Fuzhou, China
Rongbo Lin , Jinfeng Zhu , Shuitu Feng , Sunzhi Lin , Jianqian Fu , Yongzhi Yao , Lixia Hong , Min Xin , Zhangshu Chen , Zhenyu Cai , Chunxiang Li , Shen Zhao , Qingyi Wu , Shangwang Yang , Cheng Huang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Palliative Care and Symptom Management
Clinical Trial Registration Number
NCT03375515
Citation
J Clin Oncol 37, 2019 (suppl; abstr TPS11635)
DOI
10.1200/JCO.2019.37.15_suppl.TPS11635
Abstract #
TPS11635
Poster Bd #
324a
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Patient controlled analgesia (PCA) vs non-PCA intravenous hydromorphone titration for severe cancer pain: A multi-center, phase III trial, HMORCT09-1.
First Author: Rongbo Lin
Poster
2016 Palliative and Supportive Care in Oncology Symposium
Efficacy and safety of methadone in the treatment of pain in palliative care patients with cancer: The EQUIMETH2 national, randomized, open, phase III study.
First Author: Philippe Poulain
Poster
2023 ASCO Annual Meeting
Patient-controlled subcutaneous analgesia with hydromorphone versus oral oxycodone for opioid titration of cancer pain: A prospective multicenter randomized trial.
First Author: Xiaoguang Xiao
Poster
2019 Supportive Care in Oncology Symposium
Microsphere oxycodone for pain management in head and neck cancer (HNC) patients receiving radiotherapy.
First Author: Andrew McDonald